Arresto Biosciences, Inc., a biotechnology company, develops medicines to treat cancer and fibrotic diseases by targeting molecules from the extracellular matrix. The company was incorporated in 2007 and is based in Palo Alto, California.
Current Team (1)Update
|Dec 20, 2010||Dow Jones - Gilead Sciences To Acquire Arresto BioSciences For $225M Cash|
3183 Porter Drive
Palo Alto, CA 94304